Dr. Shanshan Xu is a highly accomplished professional with a diverse educational background and extensive experience in the fields of healthcare, biomedical engineering, and finance.

Dr. Xu's academic journey includes studies at prestigious institutions such as Harvard Medical School, Harvard Business School, and Harvard Law School, where they focused on Immunology, Healthcare Innovation, and Evidence Adjudication.

Furthermore, Dr. Xu holds a Certificate in Clinical Medicine from The Chinese University of Hong Kong, an M.B.A. in Finance from the Massachusetts Institute of Technology - Sloan School of Management, a Ph.D. in Biomedical Engineering from UC Irvine, and an M.S. in Biomedical Engineering.

In terms of professional experience, Dr. Xu has held various roles including Associate Analyst Equity Research at Deutsche Bank Securities and Cowen and Company, Summer Associate at Vivo Capital, Chief Representative at CIC Overseas Healthcare Innovation Fund, Senior Clinical Research Associate at Covidien, and Senior Medical Specialist at Johnson & Johnson.

Dr. Xu also has practical experience as a Resident Physician at Peking University and as an Exchange Student at The Chinese University of Hong Kong, showcasing a well-rounded background in both medical practice and academic research.

With a keen interest in the intersection of healthcare, business, and innovation, Dr. Shanshan Xu stands out as a versatile professional with a wealth of knowledge and expertise to contribute to the industry.